Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) EBIT Margin (2020 - 2026)

NeuroPace has reported EBIT Margin over the past 7 years, most recently at 25.23% for Q1 2026.

  • For Q1 2026, EBIT Margin fell 238.0% year-over-year to 25.23%; the TTM value through Mar 2026 reached 16.84%, up 602.0%, while the annual FY2025 figure was 16.34%, 1078.0% up from the prior year.
  • EBIT Margin for Q1 2026 was 25.23% at NeuroPace, down from 6.65% in the prior quarter.
  • Over five years, EBIT Margin peaked at 6.65% in Q4 2025 and troughed at 107.59% in Q2 2022.
  • A 5-year average of 43.27% and a median of 32.35% in 2024 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: plummeted -7113bps in 2022 and later surged 6002bps in 2023.
  • Year by year, EBIT Margin stood at 77.09% in 2022, then surged by 64bps to 28.04% in 2023, then surged by 39bps to 17.02% in 2024, then skyrocketed by 61bps to 6.65% in 2025, then plummeted by -280bps to 25.23% in 2026.
  • Business Quant data shows EBIT Margin for NPCE at 25.23% in Q1 2026, 6.65% in Q4 2025, and 9.51% in Q3 2025.